Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.

IBSE:ANGEN Stock Report

Market Cap: ₺2.9b

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Past Earnings Performance

Past criteria checks 0/6

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret's earnings have been declining at an average annual rate of -74%, while the Biotechs industry saw earnings growing at 11.1% annually. Revenues have been declining at an average rate of 9.2% per year.

Key information

-74.0%

Earnings growth rate

-77.8%

EPS growth rate

Biotechs Industry Growth14.8%
Revenue growth rate-9.2%
Return on equity-9.6%
Net Margin-38.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IBSE:ANGEN Revenue, expenses and earnings (TRY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24372-1442584
30 Jun 24338-1242209
31 Mar 24294-672059
31 Dec 23238-1371859
30 Sep 23486-50825512
30 Jun 23430-4032257
31 Mar 23390-3191825
31 Dec 22468-211466
30 Sep 22360526682
30 Jun 22396534591
31 Mar 22437521491
31 Dec 21410433421
31 Dec 20422293211

Quality Earnings: ANGEN is currently unprofitable.

Growing Profit Margin: ANGEN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ANGEN is unprofitable, and losses have increased over the past 5 years at a rate of 74% per year.

Accelerating Growth: Unable to compare ANGEN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ANGEN is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.1%).


Return on Equity

High ROE: ANGEN has a negative Return on Equity (-9.64%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution